- US-listed companies
- Hoth Therapeutics, Inc.
- Financials
- Proceeds from issuance of term debt, net
Hoth Therapeutics, Inc.HOTH
Market cap
$14.19M
P/E ratio
| Period End | Proceeds from issuance of term debt, net (Million USD) | YoY (%) |
|---|
| Period End | Proceeds from issuance of term debt, net (Million USD) | YoY (%) |
|---|